Becton, Dickinson & Co. (BDX)
161.69
+1.42
(+0.89%)
USD |
NYSE |
Mar 17, 16:00
161.69
0.00 (0.00%)
After-Hours: 19:41
Becton, Dickinson EPS Diluted (Quarterly) : 1.336 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 1.030 |
| Baxter International, Inc. | -2.160 |
| West Pharmaceutical Services, Inc. | 1.817 |
| Boston Scientific Corp. | 0.4493 |
| Integra LifeSciences Holdings Corp. | -0.0219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 382.00M |
| Revenue (Quarterly) | 5.252B |
| Total Expenses (Quarterly) | 4.87B |
| Enterprise Value | 64.10B |
| Gross Profit Margin (Quarterly) | 45.91% |
| Profit Margin (Quarterly) | 7.27% |
| Earnings Yield | 3.79% |
| Operating Earnings Yield | 6.98% |
| Normalized Earnings Yield | -0.4743 |